An HHS spokesperson said Dr. Jay Bhattacharya had concerns about the paper’s methodology. Some current or former CDC ...
The acting director of the Centers for Disease Control and Prevention has delayed publication of a CDC report showing the ...
Morning Overview on MSN
Once-controversial exon-skipping drugs return as hope for Duchenne
Exon-skipping therapies for Duchenne muscular dystrophy, a class of drugs that triggered fierce regulatory debate when they ...
While recent FDA guidance speaks to the agency’s support of innovative trial designs—including the use of external ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results